NCT00143624View on ClinicalTrials.gov

Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
AtherosclerosisHIV Infections
Interventions
DRUG

Rosiglitazone maleate

See Detailed Description.

DRUG

Placebo

See detailed description.

Trial Locations (1)

V6Z 1Y6

St. Paul's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT00143624 - Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels | Biotech Hunter | Biotech Hunter